NDC Code(s) : 70436-010-04, 70436-010-06, 70436-010-02, 70436-011-04, 70436-011-06, 70436-011-02
Packager : Slate Run Pharmaceuticals, LLC
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
| Bupropion Hydrochloride bupropion hydrochloride TABLET, EXTENDED RELEASE | ||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| Bupropion Hydrochloride bupropion hydrochloride TABLET, EXTENDED RELEASE | ||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| LABELER - Slate Run Pharmaceuticals, LLC(039452765) |
| REGISTRANT - Yichang Humanwell Pharmaceutical Co., Ltd.(527225336) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Yichang Humanwell Oral Solid Dosage Plant | 421371958 | manufacture(70436-010, 70436-011) | |
PRINCIPAL DISPLAY PANEL
NDC 70436-010-04
Rx only
ONCE-DAILY
Bupropion Hydrochloride Extended-release Tablets
150 mg
30 Tablets
WARNING: Do not use in combination with ZYBAN ® or any other medicines that contain bupropion hydrochloride.
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
ZYBAN ® is registered trademark of GlaxoSmithKline.
NDC 70436-010-06
Rx only
ONCE-DAILY
Bupropion Hydrochloride Extended-release Tablets
150 mg
90 Tablets
WARNING: Do not use in combination with ZYBAN ® or any other medicines that contain bupropion hydrochloride.
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
ZYBAN ® is registered trademark of GlaxoSmithKline.
NDC 70436-010-02
Rx only
ONCE-DAILY
Bupropion Hydrochloride Extended-release Tablets
150 mg
500 Tablets
WARNING: Do not use in combination with ZYBAN ® or any other medicines that contain bupropion hydrochloride.
PHARMACIST: Dispense the Medication Guide provided separately to each patient. .
ZYBAN ® is registered trademark of GlaxoSmithKline.
PRINCIPAL DISPLAY PANEL
NDC 70436-011-04
Rx only
ONCE-DAILY
Bupropion Hydrochloride Extended-release Tablets
300 mg
30 Tablets
WARNING: Do not use in combination with ZYBAN ® or any other medicines that contain bupropion hydrochloride.
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
ZYBAN ® is registered trademark of GlaxoSmithKline.
NDC 70436-011-06
Rx only
ONCE-DAILY
Bupropion Hydrochloride Extended-release Tablets
300 mg
90 Tablets
WARNING: Do not use in combination with ZYBAN ® or any other medicines that contain bupropion hydrochloride.
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
ZYBAN ® is registered trademark of GlaxoSmithKline.
NDC 70436-011-02
Rx only
ONCE-DAILY
Bupropion Hydrochloride Extended-release Tablets
300 mg
500 Tablets
WARNING: Do not use in combination with ZYBAN ® or any other medicines that contain bupropion hydrochloride.
PHARMACIST: Dispense the Medication Guide provided separately to each patient.
ZYBAN ® is registered trademark of GlaxoSmithKline.
